撤回：通过虚拟筛选设计与合成作为潜在抗癌剂的VEGFR-2酪氨酸激酶抑制剂
Retraction: Design and synthesis of VEGFR-2 tyrosine kinase inhibitors as potential anticancer agents by virtual based screening.
作者信息
Patel Harun M, Bari Pankaj, Karpoormath Rajshekhar, Noolvi Malleshappa, Thapliyal Neeta, Surana Sanjay, Jain Pritam
机构信息
Dept. of Pharmaceutical Chemistry, University of KwaZulu-Natal (Westville Campus) Private Bag X54001 Durban-4000 South Africa.
Department of Pharmaceutical Chemistry, R.C. Patel College of Pharmacy Shirpur Dhule 425405 Maharashtra India
出版信息
RSC Adv. 2025 Jun 4;15(24):18814. doi: 10.1039/d5ra90070k.
Abstract
[This retracts the article DOI: 10.1039/C5RA05277G.].
摘要
[本文撤回文章DOI: 10.1039/C5RA05277G。]
相似文献
1
Retraction: Design and synthesis of VEGFR-2 tyrosine kinase inhibitors as potential anticancer agents by virtual based screening.撤回：通过虚拟筛选设计与合成作为潜在抗癌剂的VEGFR-2酪氨酸激酶抑制剂
RSC Adv. 2025 Jun 4;15(24):18814. doi: 10.1039/d5ra90070k.
2
Virtual screening and synthesis of new chemical scaffolds as VEGFR-2 kinase inhibitors.新型化学骨架作为VEGFR-2激酶抑制剂的虚拟筛选与合成
Arzneimittelforschung. 2012 Dec;62(12):554-60. doi: 10.1055/s-0032-1323759. Epub 2012 Sep 21.
3
Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation.新型基于喹唑啉-4(3H)-酮的 VEGFR-2 激酶抑制剂的设计、合成与分子模拟及其用于潜在抗癌评估。
Bioorg Chem. 2021 Apr;109:104695. doi: 10.1016/j.bioorg.2021.104695. Epub 2021 Feb 8.
4
De novo design of VEGFR-2 tyrosine kinase inhibitors based on a linked-fragment approach.基于连接片段法的血管内皮生长因子受体-2酪氨酸激酶抑制剂的从头设计
J Mol Model. 2016 Sep;22(9):222. doi: 10.1007/s00894-016-3088-8. Epub 2016 Aug 25.
5
Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.靶向VEGFR-2酶的新型三唑并[3,4-a]酞嗪衍生物的设计、合成、体外抗癌活性、ADMET特性及分子对接
Anticancer Agents Med Chem. 2018;18(8):1184-1196. doi: 10.2174/1871520618666180412123833.
6
Computer-Aided Design of VEGFR-2 Inhibitors as Anticancer Agents: A Review.作为抗癌药物的VEGFR-2抑制剂的计算机辅助设计：综述
J Mol Recognit. 2025 Jan;38(1):e3104. doi: 10.1002/jmr.3104. Epub 2024 Oct 10.
7
Retraction.撤回。
Open Biomed Eng J. 2018 Sep 11;12:91. doi: 10.2174/1874120701812010091. eCollection 2018.
8
Retraction.撤回。
Dose Response. 2024 Oct 18;22(4):15593258241282445. doi: 10.1177/15593258241282445. eCollection 2024 Oct-Dec.
9
Virtual Screening, Docking, and Designing of New VEGF Inhibitors as Anti-cancer Agents.虚拟筛选、对接和设计新型 VEGF 抑制剂作为抗癌药物。
Curr Drug Discov Technol. 2024;21(1):e101023222024. doi: 10.2174/0115701638255384230920040154.
10
Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.合成芳基噻唑连接 2H-吲哚-2-酮衍生物作为 VEGFR-2 激酶抑制剂的分子对接和体外抗癌筛选。
Anticancer Agents Med Chem. 2022;22(11):2166-2180. doi: 10.2174/1871520621666211118102139.
引用本文的文献
1
Design, synthesis, and cytotoxic evaluation of quinazoline-based derivatives as VEGER-2 inhibitors: comparative study against EGFR kinase activity, induction of apoptosis, and molecular docking study.基于喹唑啉的衍生物作为VEGER-2抑制剂的设计、合成及细胞毒性评价：针对EGFR激酶活性、细胞凋亡诱导及分子对接研究的比较性研究
RSC Adv. 2025 Aug 21;15(36):29593-29612. doi: 10.1039/d5ra03829d. eCollection 2025 Aug 18.
Zotero 插件